Favorable Formulary Placement of Branded Drugs in Medicare Prescription Drug Plans When Generics Are Available

Author:

Socal Mariana P.1,Bai Ge2,Anderson Gerard F.1

Affiliation:

1. Department of Health Policy and Management, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

2. The Johns Hopkins Carey Business School, Baltimore, Maryland

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Reference6 articles.

1. Association of prescription drug price rebates in Medicare Part D with patient out-of-pocket and federal spending.;Dusetzina;JAMA Intern Med,2017

2. Centers for Medicare & Medicaid Services, Department of Health and Human Services. Proposed rules: Medicare program; contract year 2019 policy and technical changes to the Medicare Advantage, Medicare cost plan, Medicare fee-for-service, the Medicare prescription drug benefit programs, and the PACE program. Pages 56419-56420. https://www.gpo.gov/fdsys/pkg/FR-2017-11-28/pdf/2017-25068.pdf. Published November 28, 2017. Accessed August 14, 2018.

3. Centers for Medicare & Medicaid Services. Prescription drug plan formulary, pharmacy network, and pricing information files. https://www.cms.gov/Research-Statistics-Data-and-Systems/Files-for-Order/NonIdentifiableDataFiles/PrescriptionDrugPlanFormularyPharmacyNetworkandPricingInformationFiles.html. Updated October 3, 2018. Accessed August 14, 2018.

4. IBM. IBM Micromedex RED BOOK. http://truvenhealth.com/Products/Micromedex/Product-Suites/Clinical-Knowledge/REDBOOK. Accessed August 14, 2018.

5. ResDAC. Part D Drug Event File. https://www.resdac.org/cms-data/files/pde. Accessed August 14, 2018.

Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Drug Pricing Stewardship from Mark Cuban’s Cost Plus Generic Drug Program;PharmacoEconomics;2024-08-21

2. Generic entry and effect of market competition on outpatient pharmacy drug prices;Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector;2024-05-28

3. Role of supply chain intermediaries in steering hospital product choice: Group Purchasing Organizations and biosimilars;Health Affairs Scholar;2024-05-15

4. Why Some Patients Overpay for Specialty Generic Drugs;JAMA Internal Medicine;2024-01-01

5. Pharmacy Benefit Managers;JAMA Health Forum;2023-11-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3